美国国立综合癌症网络（NCCN）指南见解：非小细胞肺癌，2023年第2版

NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

作者信息

Ettinger David S, Wood Douglas E, Aisner Dara L, Akerley Wallace, Bauman Jessica R, Bharat Ankit, Bruno Debora S, Chang Joe Y, Chirieac Lucian R, DeCamp Malcolm, Dilling Thomas J, Dowell Jonathan, Durm Gregory A, Gettinger Scott, Grotz Travis E, Gubens Matthew A, Hegde Aparna, Lackner Rudy P, Lanuti Michael, Lin Jules, Loo Billy W, Lovly Christine M, Maldonado Fabien, Massarelli Erminia, Morgensztern Daniel, Ng Thomas, Otterson Gregory A, Patel Sandip P, Patil Tejas, Polanco Patricio M, Riely Gregory J, Riess Jonathan, Schild Steven E, Shapiro Theresa A, Singh Aditi P, Stevenson James, Tam Alda, Tanvetyanon Tawee, Yanagawa Jane, Yang Stephen C, Yau Edwin, Gregory Kristina M, Hughes Miranda

机构信息

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Fred Hutchinson Cancer Center.

出版信息

J Natl Compr Canc Netw. 2023 Apr;21(4):340-350. doi: 10.6004/jnccn.2023.0020.

DOI:10.6004/jnccn.2023.0020

PMID:37015337

Abstract

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.

摘要

美国国立综合癌症网络（NCCN）非小细胞肺癌（NSCLC）临床实践指南为NSCLC患者的疾病管理提供了建议。这些NCCN指南见解聚焦于符合条件的可切除NSCLC患者的新辅助和辅助（也称为围手术期）全身治疗方案。